4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-22-003665
Options or other derivatives
- General Counsel acquired 15,625 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
MOORE JOHN R · General Counsel
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-01 | Grant or award : show line 1 in the form Restricted Stock Units | +15,625 | 15,625 | D |
Loading xslF345X03/primarydocument.xml…